combining tirzepatide and retatrutide vs. Tirzepatide: The Next-Gen GLP-1 Showdown Retatrutide Dosage & Titration: Complete

In expanded populations, comparing semaglutide versus sitagliptin for the composite outcome of myocardial infarction or stroke yielded a hazard ratio of 0.82 (95% confidence interval (CI) 0.74 to 0.91), and comparing tirzepatide versus dulaglutide for the composite outcome including mortality yielded a hazard ratio of 0.87 (95% CI 0.75 to 1.01)

Talk to your healthcare provider about the why and when. You and your provider will want to decide when to stop tirzepatide (or taper) and when to start retatrutide

Alam S, Hasan MK, Neaz S, Hussain N, Hossain MF, Rahman T

Understanding the relationship between semaglutide therapy and neurological symptoms helps patients and clinicians distinguish medication effects from disease-related complications

Yes, Tirzepatide is FDA-approved for weight management and is proven safe when used under medical supervision

A higher step for those who tolerate treatment and need more effect